|  Help  |  About  |  Contact Us

Publication : Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting.

First Author  Chen J Year  2006
Journal  Exp Cell Res Volume  312
Issue  9 Pages  1610-25
PubMed ID  16524571 Mgi Jnum  J:111508
Mgi Id  MGI:3654235 Doi  10.1016/j.yexcr.2006.01.024
Citation  Chen J, et al. (2006) Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting. Exp Cell Res 312(9):1610-25
abstractText  Mutations in sarcoglycans have been reported to cause autosomal-recessive limb-girdle muscular dystrophies. In skeletal and cardiac muscle, sarcoglycans are assembled into a complex on the sarcolemma from four subunits (alpha, beta, gamma, delta). In this report, we present a detailed structural analysis of sarcoglycans using deletion study, limited proteolysis and co-immunoprecipitation. Our results indicate that the extracellular regions of sarcoglycans consist of distinctive functional domains connected by proteinase K-sensitive sites. The N-terminal half domains are required for sarcoglycan interaction. The C-terminal half domains of beta-, gamma- and delta-sarcoglycan consist of a cysteine-rich motif and a previously unrecognized conserved sequence, both of which are essential for plasma membrane localization. Using a heterologous expression system, we demonstrate that missense sarcoglycan mutations affect sarcoglycan complex assembly and/or localization to the cell surface. Our data suggest that the formation of a stable complex is necessary but not sufficient for plasma membrane targeting. Finally, we provide evidence that the beta/delta-sarcoglycan core can associate with the C-terminus of dystrophin. Our results therefore generate important information on the structure of the sarcoglycan complex and the molecular mechanisms underlying the effects of various sarcoglycan mutations in muscular dystrophies.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

5 Bio Entities

Trail: Publication

0 Expression